Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

1. COVID-19 & The Future Of Telemedicine: Ian Tong - CMO @ Doctor on Demand

1. COVID-19 & The Future Of Telemedicine: Ian Tong - CMO @ Doctor on Demand

FromBIOS


1. COVID-19 & The Future Of Telemedicine: Ian Tong - CMO @ Doctor on Demand

FromBIOS

ratings:
Length:
42 minutes
Released:
Mar 21, 2020
Format:
Podcast episode

Description

Ian Tong is Chief Medical Officer @ Doctor On Demand. He is also currently Clinical Assistant Professor (Affiliated) at Stanford University Medical School. Ian has spent his career working to improve access to high quality care and brings this dedication to his work at Doctor On Demand.Prior to joining Doctor On Demand, Ian held several medical leadership roles. He served as Stanford Internal Medicine Chief Resident; Co-Medical Director of the Arbor Free Clinic; and Founder and Medical Director of The Health Resource Initiative for Veterans Everywhere (THRIVE) at the VA Palo Alto Health Care System, which was honored in 2008 by the U.S. Secretary of Veterans Affairs with the Award for Outstanding Achievement in Service to Homeless Veterans. Before becoming Chief Medical Officer, Ian served as Medical Director at Doctor On Demand.Ian is a National Collegiate Champion in Rugby at the University of California at Berkeley and was named to the All American Team in 1994. He graduated with a BA in English. He earned a medical degree from The University of Chicago – Pritzker and completed residency and Chief residency at Stanford Hospital and Clinics. He is board certified in Internal Medicine.Ian lives in the San Francisco Bay Area with his wife and three children. He is most proud of the relationships he has built working alongside his family, friends, teammates, students and colleagues to positively impact the lives of others.The COVID-19 pandemic is creating an inflection point in healthcare delivery and innovation. Telemedicine is playing a central role in combating the novel coronavirus outbreak, and the telehealth industry will emerge from the pandemic with new winners, losers, and structural changes.Topics:State of the pandemic and the role of telemedicine in combating itThe impact of COVID on the telehealth industryTelemedicine winners and losers in aftermath of COVID: from point solutions to integrated longitudinal careThe power of retail clinics both during the pandemic and long term in telehealth and care deliveryStructural and policy changes needed for future pandemics and for the advancement of telemedicineThank you for listening!BIOS (@BIOS_Community) unites a community of Life Science innovators dedicated to driving patient impact. Alix Ventures (@AlixVentures) is a San Francisco based venture capital firm supporting early stage Life Science startups engineering biology to create radical advances in human health.Music: Danger Storm by Kevin MacLeod (link & license) 
Released:
Mar 21, 2020
Format:
Podcast episode

Titles in the series (63)

BIOS Podcast brings together cutting-edge insights from Life Science industry leaders at the forefront of innovation. Join us in hearing from Founders, Investors, Professors, & Pharma operating at the intersection of Technology & Biology. By Alix Ventures: Driving Patient Impact - Supporting early stage Life Science startups engineering biology to drive radical advances in human health. Learn more @ BIOS.community / Alix.vc __________________________________ Alix Ventures, by way of BIOS Community, is providing this content for general information purposes only. Reference to any specific product or entity does not constitute an endorsement nor recommendation by Alix Ventures, BIOS Community, or its affiliates. The views & opinions expressed by guests are their own & their appearance on the program does not imply an endorsement of them nor any entity they represent. Views & opinions expressed by Alix Ventures employees are those of the employees & do not necessarily reflect the view of Alix Ventures, BIOS Community, affiliates, nor its content sponsors.